Samantha Olson, MPH, highlights how maternal vaccination protects infants from influenza.
Following positive results from a study published in JAMA Pediatrics, study investigator Samantha Olson, MPH, epidemiologist, Influenza Division, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, joined Contemporary Pediatrics to explain the importance of maternal influenza vaccination and its association with infant protection.
"We know that infants have a high risk of hospitalization for influenza and other serious influenza complications," Olson said. "Infants are not eligible to receive that flu vaccine until they're 6 months of age, so really, mothers getting vaccinated during pregnancy provide that protection for both themselves and their infants until they're eligible for vaccination."
Olson also reminds providers that influenza is still in season.
"We expect flu cases to remain elevated over the next couple of weeks," said Olson. "So it's not too late to get vaccinated for pregnant persons, for those considering becoming pregnant, or those who are postpartum. It's not too late to receive that flu vaccine to provide protection to both themselves and their babies."
"Also to the pediatricians, children 6 months and older are eligible for flu vaccination, so it is not too late for them to get vaccinated."
In Olson and colleagues' study published in JAMA Pediatrics, results revealed that maternal vaccination was associated with a reduction in influenza-associated hospitalizations and ED visits in infants, providing protection until vaccine eligibility for infants at 6 months of age.
This is the second video interview with Samantha Olson, MPH. Click here to view the first episode.
This interview was initially published by our sister publication Contemporary Pediatrics.
Reference:
Sahni LC, Olson SM, Halasa NB, et al. Maternal vaccine effectiveness against influenza-associated hospitalizations and emergency department visits in infants. JAMA Pediatr. 2024;178(2):176–184. doi:10.1001/jamapediatrics.2023.5639
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Key biomarkers for predicting congenital cytomegalovirus
December 26th 2024A new study highlights the prognostic value of thrombocytes, β2-microglobulin, and cytomegalovirus viral load in assessing congenital cytomegalovirus infection, offering insights for improved prenatal counseling.
Read More
Study shows a healthy prenatal diet could be upstream obesity prevention strategy
December 26th 2024"Our findings support the recommendation of a healthy diet based on the current guidelines (as measured by the HEI) during pregnancy, since it may reduce patterns of infant growth outside reference ranges."
Read More